The Role of Fas-mediated Apoptosis in Thyroid Autoimmune Disease

References

• C.B. Thompson, Apoptosis in the pathogenesis and treatment of disease. Science 1995: 261: 1456 1462.
   Google Scholar
• M.J. Arends and A.U. Wyllie, Apoptosis: mechanisms and roles in pathology. International Review oj Experimental Pathology 1991; 32: 223–254.
   PubMedGoogle Scholar
• R.C. Duke, D.M. Ojcius and J.D. Young, Cell suicide in health and disease. Scientific American 1996; 275: 80 87.
   Google Scholar
• A.H. Wyllie, Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284: 555 556.
   PubMedGoogle Scholar
• C.A. Smith, G.T. Williams, R. Kingston, E.J. Jenkinson and J.J. Owen, Antibodies to CD3 T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 1989; 337: 181 184.
   PubMedGoogle Scholar
• M. Barinaga, Is apoptosis key in Alzheimer's disease? Science 1998; 281: 1303–1304.
   PubMedGoogle Scholar
• A. Ashkenazi and V.M. Dixit, Death receptors: signaling and modulation. Science 1998; 281: 1305 1308.
   Google Scholar
• N.A. Thornberry and Y. Lazebnik, Caspases: enemies within. Science 1998; 281: 1312 1316.
   Google Scholar
• J.P. Sheridan, S.A. Marsters. R.M. Pitti, A. Gurney, M. Skubatch, D. Baldwin et al., Control of TRA1L-induced apoptosis by a family of signaling and decoy receptors. Science 1997; 277: 818–821.
   Google Scholar
• R.M. Pitti, S.A. Marsters, D.A. Lawrence. M. Roy, F.C. Kischkel, P. Dowd et ai, Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 1998; 396: 699–703.
   PubMedGoogle Scholar
• N. Itoh, S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima et al., The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233–243.
   Google Scholar
• T. Suda, T. Takahashi, P. Golstein and S. Nagata, Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169–1178.
   PubMedGoogle Scholar
• M. Muzio, A.M. Chinnaiyan, F.C. Kischkel, K. O'Rourke, A. Shevchenko, J. Ni et al., FLICE, a novel FADD-homologous ICE CED-3-like protease, is recruited to the CD95 (Fas APO-1) death-inducing signaling complex. Cell 1996; 85: 817 827.
   Google Scholar
• F.C. Kischekel, S. Hellbardt, I. Behrmann, M. Germer, M. Pawlita, P.H. Krammer et al., Cytotoxicity-dependent APO-1 (Fas.CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO Journal 1995; 14: 5579–5588.
   Google Scholar
• G. Pan, K. O'Rourke, A.M. Chinnaiyan, R. Gentz. R. Ebner, J. Ni et al., The receptor for the cytotoxic ligand TRAIL. Science 1997; 276: 111 113.
   Google Scholar
• J.W. Kappler, N. Roehm and P. Marrack, T cell tolerance by clonal elimination in the thymus. Cell 1987; 49: 273–280.
   PubMedGoogle Scholar
• G.J. Nossal, Negative selection of lymphocytes. Cell 1994: 76: 229–239.
   PubMedGoogle Scholar
• K.M. Murphy, A.B. Heimberger and D.Y. Loh, Induction by antigen of intrathymic apoptosis of CD4 ( CD8 + TCRlo thymocytes in vivo. Science 1990; 250: 1720-1723.
   Google Scholar
• W. Swat, L. Ignatowicz, H. von Boehmerand P. Kisielow, Clonal deletion of immature CD4 + 8 + thymocytes in suspension culture by extrathymic antigen-presenting cells. Nature 1991; 351: 150 153.
   Google Scholar
• W. Swat. L. Ignatowiczand P. Kisielow, Detection of apoptosis of immature CD4 +8 +thymocytes by flow cytometry. Journal of Immunological Methods 1991: 137: 79 87.
   Google Scholar
• R. Watanabe-Fukunaga. C.l. Brannan, N.G. Copeland, N.A. Jenkins and S. Nagata, Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992: 356: 314–317.
   Google Scholar
• E.M. Tan, Autoimmunity and apoptosis [comment]. Journal of Experimental Medicine 1994; 179: I083–I086.
   Google Scholar
• P.L. Cohen and R.A. Eisenberg, Lpr and gld: single gene models of systemic autoimmunity and Iymphoproliferative disease. Annual Review oj Immunology 1991; 9: 243 269.
   Google Scholar
• D.H. Lynch, M.L. Watson, M.R. Alderson, P.R. Baum, R.E. Miller, T. Tough et ai. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Imnntnitv 1994; I: 131–136.
   Google Scholar
• F. Ramsdell. M.S. Seaman, R.E. Miller, T.W. Tough, M.R. Alderson and D.H. Lynch, gld gld mice are unable to express a functional ligand for Fas. European Journal of Immunology 1994; 24: 928–933.
   PubMedGoogle Scholar
• K.B. Elkon, Apoptosis and autoimmunity. Journal of Rheumatology 1997; 24: 6–7.
   PubMedGoogle Scholar
• J.D. Mountz, J. Wu, J. Cheng and T Zhou. Autoimmune disease. A problem of defective apoptosis. Arthritis and Rheumatism 1994; 37: 1415 1420.
   Google Scholar
• T. Hunig and A. Schimpl, Systemic autoimmune disease as a consequence of defective lymphocyte death. Current Opinion in Immunology 1997; 9: 826 830.
   Google Scholar
• C. Benoist and D. Mathis, Cell death mediators in autoimmune diabetes-no shortage of suspects Cell 1997: 89: 1–3.
   Google Scholar
• R. De Maria and R. Testi, Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity. Immunologv Today 1998; 19: 121–125.
   PubMedGoogle Scholar
• L.J. Hammond, M.W. ' Lowdell, P.G. Cerrano, A.W. Goode, G.F. Bottazzo and R. Mirakian, Analysis of apoptosis in relation to tissue destruction associated with Hashimoto's autoimmune thyroiditis. Journal of Pathology 1997; 182: 138–144.
   Google Scholar
• Okayasu, M. Saegusa, M. Fujiwara, Y. Hara and N.R. Rose, Enhanced cellular proliferative activity and cell death in chronic thyroiditis and thyroid papillary carcinoma. Journal of Cancer Research and Clinical Oncology 1995; 121: 746 752.
   Google Scholar
• T. Kotani, Y. Aratake, K. Hirai, Y. Fukazawa, H. Sato and S. Ohtaki, Apoptosis in thyroid tissue from patients with Hashimoto's thyroiditis. Autoimmunity 1995; 20: 231–236.
   PubMedGoogle Scholar
• C. Tanimoto, S. Hirakawa, H. Kawasaki, N. Hayakawa and Z. Ota, Apoptosis in thyroid diseases: a histochemical study. Endocrine Journal 1995: 42: 193–201.
   PubMedGoogle Scholar
• N. Mitsiades. V. Poulaki, V. Kotoula, G. Mastorakos, S. Tseleni-Balafouta, D.A. Koutras et al., Fas Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis. Journal of Clinical Endocrinology and Metabolism 1998; 83: 2199–2203.
   Google Scholar
• G.F. Del Prete, D. Vercelli, A. Tiri, E. Maggi, S. Mariotti, A. Pinchera et al., In vivo activated cytotoxic T cells in the thyroid infiltrate of patients with Hashimoto's thyroiditis. Clinical and Experimental Immunology 1986; 65: 140–147.
   Google Scholar
• W.A. MacKenzie, A.E. Schwartz, E.W. Friedman and T.F. Davies, lntrathyroidal T cell clones from patients with autoimmune thyroid disease. Journal of Clinical Endocrinology and Metabolism 1987; 64: 818–824.
   PubMedGoogle Scholar
• G. Stassi, M. Todaro, F. Buccliieri, A. Stoppacciaro, F. Farina, G. Zummo et ai, Fas Fas ligand-driven T celi apoptosis as a consequence of ineffective thyroid immu-noprivilege in Hashimoto's thyroiditis. Journal of Immunology 1999; 162: 263 267.
   Google Scholar
• C. Giordano, G. Stassi, R. De Maria, M. Todaro, P. Richiusa, G. Papoff et al.. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 1997; 275: 960–963.
   Google Scholar
• A. Kawakami, K. Eguchi, N. Matsuoka, M. Tsuboi, S. Urayama, Y. Kawabe et al., Modulation of Fas-mediated apoptosis of human thyroid epithelial cells by IgG from patients with Graves' disease (GD) and idiopathic myxoedema. Clinical and Experimental Immunologv 1997: 110: 434–439.
   Google Scholar
• T. Suda, T. Okazaki, Y. Naito, T. Yokota, N. Arai, S. Ozaki el al., Expression of the Fas ligand in cells of T cell lineage. Journal of Immunologv 1995; 154: 3806–3813.
   Google Scholar
• G. Berke, The CTL's kiss of death. Cell 1995; 81: 9 12.
   Google Scholar
• T.S. Griffith and T.A. Ferguson, The role of FasL-induced apoptosis in immune privilege [published erratum appears in Imnumologv Today 1997 Jul; 18(7): 361], Immunologv Toclav 1997; 18: 240–244.
   Google Scholar
• M.W. Bennett, J. O'Connell, G.C. O'Sullivan, C. Brady, D. Roche, J.K. Collins et ai, The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma. Journal of Immunology 1998; 160: 5669–5775.
   PubMedGoogle Scholar
• D.B. Chappell and N.P. Restifo, T cell-tumor cell: a fatal interaction? Cancer Immunologv, Immunotlierapv 1998; 47: 65 71.
   Google Scholar
• M. Hahne, D. Rimoldi, M. Schroter, P. Romero, M. Schreier, L.E. French et al., Melanoma cell expression of Fas(Apo-l/CD95) ligand: implications for tumor immune escape. Science 1996; 274: 1363 1366.
   Google Scholar
• P. Saas, P.R. Walker, M. Hahne, A.L. Quiquerez, V. Schnuriger, G. Perrin et al., Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? Journal of Clinical Investigation 1997; 99: 1173 1178.
   Google Scholar
• A. Villunger, A. Egle, 1. Marschitz, M. Kos, G. Bock, H. Ludwig el al., Constitutive expression of Fas (Apo-I CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillance. Blood 1997; 90: 12 20.
   Google Scholar
• T.A. Stokes, M. Rymaszewski, P.L. Arscott, S.H. Wang, J.D. Bretz, J.L. Bartron et al., Constituitive expression of FasL in thyrocytes. Science 1998; 279: 2015a.
   Google Scholar
• P. Fiedler, CE. Schaetzlein and H. Eibel, Constituitive expression of FasL in thyrocytes. Science 1998; 279: 2015a.
   Google Scholar
• D. Smith, S. Sieg and D. Kaplan, Technical note: Aberrant detection of cell surface Fas ligand with anti-peptide antibodies. Journal of Immunology 1998; 160: 4159–4160.
   PubMedGoogle Scholar
• L. Xerri, E. Devilard, J. Hassoun, C. Mawas and F. Birg, Fas ligand is not only expressed in immune privileged human organs but is also coexpressed with Fas in various epithelial tissues. Molecular Pathology 1997; 50: 87 91.
   Google Scholar
• M. Tamura, H. Kimura, T. Koji, T. Tominaga, K. Ashizawa, T. Kiriyama el al., Role of apoptosis of thyrocytes in a rat model of goiter. A possible involvement of Fas system. Endocrinology 1998; 139: 3646 3653.
   Google Scholar
• F. Leithauser, J. Dhein, G. Mechtersheimer, K. Koretz. S. Bruderlein, C. Henne el al.. Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Laboratory Investigation 1993; 69: 415 429.
   Google Scholar
• A. Kawakami. K. Eguchi, N. Matsuoka, M. Tsuboi. Y. Kawabe, N. Ishikawa et al., Thyroid-stimulating hormone inhibits Fas antigen-mediated apoptosis of human thyrocytes in vitro. Endocrinology 1996: 137: 3163–3169.
   Google Scholar
• P.L. Arscott, J. Knapp, M. Rymaszewski, J.L. Bartron. J.D. Bretz, N.W. Thompson et al., Fas (APO-I, CD95)-mediated apoptosis in thyroid cells is regulated by a labile protein inhibitor. Endocrinology 1997; 138: 5019–5027.
   Google Scholar
• T. Suda and S. Nagata, Purification and characterization of the Fas-ligand that induces apoptosis. Journal of Experimental Medicine 1994; 179: 873–879.
   PubMedGoogle Scholar
• T. Sato, S. Irie, S. Kitada and J.C. Reed, FAP-1: a protein tyrosine phosphatase that associates with Fas. Science I995;268:411 415.
   Google Scholar
• A. Myc, P.L. Arscott and J.R. Baker, Jr., FAP-I is present in human thyroid follicular cells and functions as an inhibitor of Fas-mediated signaling of programmed cell death. The American Thyroid Association 71s' Annual Meeting, September 16 20, 1998, Portland, Oregon.
   Google Scholar
• D. Hockenbery, G. Nunez, C. Milliman, R.D. Schreiber and S.J. Korsmeyer, Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334–336.
   PubMedGoogle Scholar
• CL. Sentman, J.R. Shutter, D. Hockenbery, O. Kanagawa and S.J. Korsmeyer, Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 1991; 67: 879–888.
   PubMedGoogle Scholar
• N. Itoh, Y. Tsujimoto and S. Nagata, Effect of bcl-2 on Fas antigen-mediated cell death. Journal of Immunology 1993; 151: 621 627.
   Google Scholar
• A. Kuwuliuru. T. Kobayashi and S. Nagata, Inhibition of Fas-induced apoptosis by Bcl-2. Oncogene 1998: 17: 2549–2554.
   PubMedGoogle Scholar
• V.K.. Chil, CM. Walsh, C.C. Liu, J.C. Reed and W.R. Clark, Bcl-2 blocks degranulation but not fas-based cell-mediated cytotoxicity. Journal of Immunology 1995: 154: 2023–2032.
   PubMedGoogle Scholar
• A. Strasser, A.W. Harris, D.C. Huang, P.H. Krammer and S. Cory, Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EM BO Journal 1995: 14: 6136–6147.
   PubMedGoogle Scholar
• L. Van Parijs, A. Biuckians and A.K.. Abbas, Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes. Journal of Immunology 1998; 160: 2065–2071.
   PubMedGoogle Scholar
• C. Scaffidi, S. Fulda, A. Srinivasan, C. Friesen, F. Li, K..J. Tomaselli et al., Two CD95 (APO-I/Fas) signaling pathways. EMBO Journal 1998; 17: I675–I687.
   Google Scholar
• S. Hu, C. Vincenz, J. Ni, R. Gentz and V.M. Dixit, 1-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis. Journal of Biological Chemistry 1997; 272: 17 255 17257.
   Google Scholar
• M. Irmler, M. Thome, M. Hahne, P. Schneider, K. Hofmann, V. Steiner et al., Inhibition of death receptor, signals by cellular FLIP [see comments]. Nature 1997:388: 190–195.
   Google Scholar
• CM. Dayan, K.A. Elsegood and R. Maile, FasL expression on epithelial cells: the Bottazzo Feldman hypothesis revisited [see comments], Immunolog\ Today 1997; 18: 203.
   Google Scholar